ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 308 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $354,280 | -13.0% | 17,000 | 0.0% | 0.05% | -8.5% |
| Q2 2023 | $407,150 | +27.3% | 17,000 | 0.0% | 0.06% | +20.4% |
| Q1 2023 | $319,940 | +18.2% | 17,000 | 0.0% | 0.05% | +11.4% |
| Q4 2022 | $270,640 | -2.6% | 17,000 | 0.0% | 0.04% | -8.3% |
| Q3 2022 | $278,000 | +15.8% | 17,000 | 0.0% | 0.05% | +23.1% |
| Q2 2022 | $240,000 | -41.7% | 17,000 | 0.0% | 0.04% | -30.4% |
| Q1 2022 | $412,000 | +3.8% | 17,000 | 0.0% | 0.06% | +12.0% |
| Q4 2021 | $397,000 | +40.8% | 17,000 | 0.0% | 0.05% | +31.6% |
| Q3 2021 | $282,000 | -32.0% | 17,000 | 0.0% | 0.04% | -30.9% |
| Q2 2021 | $415,000 | -5.5% | 17,000 | 0.0% | 0.06% | -11.3% |
| Q1 2021 | $439,000 | -51.7% | 17,000 | 0.0% | 0.06% | -55.7% |
| Q4 2020 | $909,000 | +29.7% | 17,000 | 0.0% | 0.14% | +11.1% |
| Q3 2020 | $701,000 | -14.9% | 17,000 | 0.0% | 0.13% | -18.7% |
| Q2 2020 | $824,000 | +14.8% | 17,000 | 0.0% | 0.16% | -5.5% |
| Q1 2020 | $718,000 | -1.2% | 17,000 | 0.0% | 0.16% | +33.3% |
| Q4 2019 | $727,000 | +18.8% | 17,000 | 0.0% | 0.12% | +9.8% |
| Q3 2019 | $612,000 | +34.8% | 17,000 | 0.0% | 0.11% | +38.3% |
| Q2 2019 | $454,000 | -19.5% | 17,000 | -19.0% | 0.08% | -21.4% |
| Q1 2019 | $564,000 | +65.9% | 21,000 | 0.0% | 0.10% | +45.1% |
| Q4 2018 | $340,000 | -48.8% | 21,000 | -34.4% | 0.07% | -37.2% |
| Q3 2018 | $664,000 | +8.7% | 32,000 | -20.0% | 0.11% | +3.7% |
| Q2 2018 | $611,000 | – | 40,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |